Anaprazole

Anaprazole
Identifiers
	IUPAC name 2-[[3-(3-methoxypropoxy)-2-methylphenyl]methylsulfinyl]-6,7-dihydro-1H-furo[2,3-f]benzimidazole;
PubChem CID	156009457;
ChemSpider	128732661; Na+ salt: 128433794;
UNII	W6OO9ZB0FC;
ChEMBL	ChEMBL4651083; Na+ salt: ChEMBL4650347;
Chemical and physical data
Formula	C21H24N2O4S
Molar mass	400.49 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC1=C(C=CC=C1OCCCOC)CS(=O)C2=NC3=C(N2)C=C4CCOC4=C3;
	InChI InChI=InChI=1S/C21H24N2O4S/c1-14-16(5-3-6-19(14)26-9-4-8-25-2)13-28(24)21-22-17-11-15-7-10-27-20(15)12-18(17)23-21/h3,5-6,11-12H,4,7-10,13H2,1-2H3,(H,22,23); Key:JYSIFLQJDVIWKM-UHFFFAOYSA-N;

PubChem CID

156009457

ChemSpider

128732661
Na⁺ salt: 128433794

UNII

W6OO9ZB0FC

ChEMBL

ChEMBL4651083
Na⁺ salt: ChEMBL4650347

Anaprazole is a pharmaceutical drug used for the treatment of duodenal ulcers. It is classified as a proton pump inhibitor (PPI).^[1] It was approved for use in China in 2023.^[2] It is formulated as its sodium salt, anaprazole sodium, in enteric-coated tablets.^[2]

[1]

[2]

v t e Drugs for peptic ulcer and GERD/GORD (A02B)
H₂ antagonists ("-tidine")	Cimetidine Famotidine Lafutidine Lavoltidine (loxtidine) Niperotidine Nizatidine Ranitidine^# Roxatidine
Prostaglandins (E)/ analogues ("-prost-")	Misoprostol Enprostil
Proton-pump inhibitors ("-prazole")	Anaprazole Azeloprazole Dexlansoprazole Dexrabeprazole Esomeprazole Ilaprazole Lansoprazole Omeprazole^# Pantoprazole Picoprazole Rabeprazole Tenatoprazole Timoprazole
Potassium-competitive acid blockers ("-prazan")	Fexuprazan Linaprazan Revaprazan Soraprazan Tegoprazan Vonoprazan Zastaprazan
Others	Aceglutamide aluminum Acetoxolone Alginic acid Arbaclofen placarbil Bismuth subcitrate Carbenoxolone Cetraxate Gefarnate Irsogladine Lesogaberan Pirenzepine Proglumide Rebamipide Sucralfate Sulglicotide Telenzepine Teprenone Troxipide Zinc L-carnosine Zolimidine
Combinations	Bismuth subcitrate/metronidazole/tetracycline Omeprazole/amoxicillin/rifabutin Vonoprazan/amoxicillin Vonoprazan/amoxicillin/clarithromycin
See also: Helicobacter pylori* eradication protocols*
^#WHO-EM ^‡Withdrawn from market Clinical trials: ^†Phase III ^§Never to phase III

Identifiers

IUPAC name 2-[[3-(3-methoxypropoxy)-2-methylphenyl]methylsulfinyl]-6,7-dihydro-1H-furo[2,3-f]benzimidazole
PubChem CID	156009457
ChemSpider	128732661 Na⁺ salt: 128433794
UNII	W6OO9ZB0FC
ChEMBL	ChEMBL4651083 Na⁺ salt: ChEMBL4650347
Chemical and physical data
Formula	C₂₁H₂₄N₂O₄S
Molar mass	400.49 g·mol⁻¹
3D model (JSmol)	Interactive image
SMILES CC1=C(C=CC=C1OCCCOC)CS(=O)C2=NC3=C(N2)C=C4CCOC4=C3
InChI InChI=InChI=1S/C21H24N2O4S/c1-14-16(5-3-6-19(14)26-9-4-8-25-2)13-28(24)21-22-17-11-15-7-10-27-20(15)12-18(17)23-21/h3,5-6,11-12H,4,7-10,13H2,1-2H3,(H,22,23) Key:JYSIFLQJDVIWKM-UHFFFAOYSA-N

Related Articles